Ardelyx Inc. buy BiotechBee
Start price
08.09.22
/
50%
€1.29
Target price
31.12.24
€2.00
Performance (%)
31.25%
End price
09.12.22
€1.70
Summary
This prediction ended on 09.12.22 with a price of €1.70. With a performance of 31.25% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Ardelyx Inc. where he still thinks Ardelyx Inc. is a Buy. BiotechBee has 50% into this predictionArdelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ardelyx Inc. | 40.927% | 40.927% | 104.125% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to BiotechBee what are the pros and cons of Ardelyx Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ardelyx Inc. diskutieren
Kursziel geändert auf 2,0
In the thread Trading Ardelyx Inc.
Current prediction by BiotechBee for Ardelyx Inc.
Ardelyx Inc.
Start price
Target price
Perf. (%)
€8.30
17.02.24
17.02.24
€11.00
31.01.26
31.01.26
2.72%
09:30
09:30
Could be very worthwhile Investment >20% year
